{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:12Z","timestamp":1790999712696,"version":"4.1.0"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7538-26","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:11:43Z","timestamp":1790633503000},"source":"Crossref","is-referenced-by-count":0,"title":["Aseptic Meningitis Unmasking Coccidioidomycosis of the Central Nervous System Outside an Endemic Region"],"prefix":"10.2169","author":[{"given":"Shunsuke","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, John A. Burns School of Medicine, University of Hawai\u02bbi, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, Aloha Critical Care Associates, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Hamahata","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, Aloha Critical Care Associates, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bajwa AK, Rongkavilit C. Update on coccidioidomycosis in the United States and beyond. Glob Pediatr Heal 7: 2333794X20969282, 2020.","DOI":"10.1177\/2333794X20969282"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lang R, Stokes W, Lemaire J, Johnson A, Conly J. A case report of Coccidioides posadasii meningoencephalitis in an immunocompetent host. BMC Infect Dis 19: 722, 2019.","DOI":"10.1186\/s12879-019-4329-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis 63: e112-e146, 2016.","DOI":"10.1093\/cid\/ciw360"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol 17: 362-372, 2018.","DOI":"10.1016\/S1474-4422(18)30030-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cheok LH, Lee WWH, Cheng WM, Cheong YK, Teh CL. Aseptic meningitis as initial manifestation of systemic lupus erythematosus: case series. Lupus 31: 373-377, 2022.","DOI":"10.1177\/09612033221078213"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Romeo JH, Rice LB, McQuarrie IG. Hydrocephalus in coccidioidal meningitis: case report and review of the literature. Neurosurgery 47: 773, 2000.","DOI":"10.1227\/00006123-200009000-00051"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ho J, Fowler P, Heidari A, Johnson RH. Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis. Clin Infect Dis 64: 519-524, 2017.","DOI":"10.1093\/cid\/ciw794"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee S-A, Kim S-W, Chang H-H, et al. A new scoring system for the differential diagnosis between tuberculous meningitis and viral meningitis. J Korean Med Sci 33: e201, 2018.","DOI":"10.3346\/jkms.2018.33.e201"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Donovan FM, Wightman P, Zong Y, et al. Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA. Emerg Infect Dis 25: 1745-1747, 2019.","DOI":"10.3201\/eid2508.190023"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Stott KE, Loyse A, Jarvis JN, et al. Cryptococcal meningoencephalitis: time for action. Lancet Infect Dis 21: e259-e271, 2021.","DOI":"10.1016\/S1473-3099(20)30771-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ravi N, Elkurdi R, Lietz AJ, Grys T, Grill M, Blair JE. Real-world performance of diagnostic testing for coccidioidal meningitis in initial sampling of the cerebrospinal fluid. Med Mycol 63: myaf082, 2025.","DOI":"10.1093\/mmy\/myaf082"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vucicevic D, Blair JE, Binnicker MJ, et al. The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia 170: 345-351, 2010.","DOI":"10.1007\/s11046-010-9327-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dizon D, Mitchell M, Dizon B, Libke R, Peterson MW. The utility of real-time polymerase chain reaction in detecting Coccidioides immitis among clinical specimens in the Central California San Joaquin Valley. Med Mycol 57: 688-693, 2019.","DOI":"10.1093\/mmy\/myy111"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Galgiani JN, Hsu AP, Powell DA, Vyas JM, Holland SM. Genetic and other determinants for the severity of coccidioidomycosis: a clinician\u2019s perspective. J Fungi 9: 554, 2023.","DOI":"10.3390\/jof9050554"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62: e1-e50, 2016.","DOI":"10.1093\/cid\/civ933"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. McHardy IH, Barker B, Thompson GR. Review of clinical and laboratory diagnostics for coccidioidomycosis. J Clin Microbiol 61: e01581-22, 2023.","DOI":"10.1128\/jcm.01581-22"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Heidari A, Quinlan M, Benjamin DJ, et al. Isavuconazole in the treatment of coccidioidal meningitis. Antimicrob Agents Chemother 63: 10.1128\/aac.02232-18, 2018.","DOI":"10.1128\/AAC.02232-18"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Wiederhold NP, Najvar LK, Jaramillo R, et al. The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis. Antimicrob Agents Chemother 62: 10.1128\/aac.00999-18, 2018.","DOI":"10.1128\/AAC.00999-18"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wiederhold NP, Patterson HP, Ferrer D, Garcia V, Thompson GR, Patterson TF. Olorofim demonstrates in vitro activity against Coccidioides species, including isolates against which fluconazole has reduced activity. Antimicrob Agents Chemother 69: e00988-24, 2024.","DOI":"10.1128\/aac.00988-24"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7538-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:29:56Z","timestamp":1790998196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7538-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7538-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7538-26"}}